GB0226993D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0226993D0
GB0226993D0 GB0226993A GB0226993A GB0226993D0 GB 0226993 D0 GB0226993 D0 GB 0226993D0 GB 0226993 A GB0226993 A GB 0226993A GB 0226993 A GB0226993 A GB 0226993A GB 0226993 D0 GB0226993 D0 GB 0226993D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0226993A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0226993A priority Critical patent/GB0226993D0/en
Priority to US10/313,709 priority patent/US20040097419A1/en
Publication of GB0226993D0 publication Critical patent/GB0226993D0/en
Priority to RU2005119632/15A priority patent/RU2404748C2/en
Priority to PL03376015A priority patent/PL376015A1/en
Priority to MXPA05005388A priority patent/MXPA05005388A/en
Priority to ES11173962.9T priority patent/ES2577613T3/en
Priority to EP11173962.9A priority patent/EP2377519B1/en
Priority to KR1020057008892A priority patent/KR101146471B1/en
Priority to EP03789053A priority patent/EP1565161A2/en
Priority to AU2003293700A priority patent/AU2003293700A1/en
Priority to PCT/EP2003/012898 priority patent/WO2004045633A2/en
Priority to PT111739629T priority patent/PT2377519E/en
Priority to BR0316421-7A priority patent/BR0316421A/en
Priority to CNB2003801032495A priority patent/CN100400098C/en
Priority to JP2004552645A priority patent/JP2006514927A/en
Priority to KR1020127001817A priority patent/KR101240071B1/en
Priority to CA2501978A priority patent/CA2501978C/en
Priority to ZA200502748A priority patent/ZA200502748B/en
Priority to EC2005005800A priority patent/ECSP055800A/en
Priority to CO05050166A priority patent/CO5690533A2/en
Priority to NO20052952A priority patent/NO20052952L/en
Priority to HK12101942.3A priority patent/HK1161123A1/en
Priority to US11/650,701 priority patent/US20070122485A1/en
Priority to AU2008200018A priority patent/AU2008200018B2/en
Priority to RU2010144614/15A priority patent/RU2010144614A/en
Priority to AU2011200966A priority patent/AU2011200966B2/en
Priority to JP2011165812A priority patent/JP5784402B2/en
Priority to US14/330,485 priority patent/US20140323415A1/en
Priority to US15/627,619 priority patent/US20170281548A1/en
Priority to US16/576,217 priority patent/US20200009056A1/en
Priority to US17/748,432 priority patent/US20220273574A1/en
Ceased legal-status Critical Current

Links

GB0226993A 2002-11-19 2002-11-19 Organic compounds Ceased GB0226993D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GB0226993A GB0226993D0 (en) 2002-11-19 2002-11-19 Organic compounds
US10/313,709 US20040097419A1 (en) 2002-11-19 2002-12-06 Organic compounds
AU2003293700A AU2003293700A1 (en) 2002-11-19 2003-11-18 Pharmaceutical composition comprising octreotide microparticles
JP2004552645A JP2006514927A (en) 2002-11-19 2003-11-18 Pharmaceutical composition comprising octreotide microparticles
CA2501978A CA2501978C (en) 2002-11-19 2003-11-18 Pharmaceutical composition comprising octreotide microparticles
MXPA05005388A MXPA05005388A (en) 2002-11-19 2003-11-18 Pharmaceutical composition comprising octreotide microparticles.
ES11173962.9T ES2577613T3 (en) 2002-11-19 2003-11-18 Pharmaceutical composition comprising octreotide microparticles
EP11173962.9A EP2377519B1 (en) 2002-11-19 2003-11-18 Pharmaceutical Composition Comprising Octreotide Microparticles
KR1020057008892A KR101146471B1 (en) 2002-11-19 2003-11-18 Pharmaceutical Composition Comprising Octreotide Microparticles
EP03789053A EP1565161A2 (en) 2002-11-19 2003-11-18 Pharmaceutical composition comprising octreotide microparticles
PL03376015A PL376015A1 (en) 2002-11-19 2003-11-18 Pharmaceutical composition comprising octreotide microparticles
PCT/EP2003/012898 WO2004045633A2 (en) 2002-11-19 2003-11-18 Pharmaceutical composition comprising octreotide microparticles
PT111739629T PT2377519E (en) 2002-11-19 2003-11-18 Pharmaceutical composition comprising octreotide microparticles
BR0316421-7A BR0316421A (en) 2002-11-19 2003-11-18 Pharmaceutical composition comprising octreotide microparticles
CNB2003801032495A CN100400098C (en) 2002-11-19 2003-11-18 Medicine composition containing octreotide grains
RU2005119632/15A RU2404748C2 (en) 2002-11-19 2003-11-18 Pharmaceutical composition, containing octreotide microparticles
KR1020127001817A KR101240071B1 (en) 2002-11-19 2003-11-18 Pharmaceutical Composition Comprising Octreotide Microparticles
ZA200502748A ZA200502748B (en) 2002-11-19 2005-04-05 Pharmaceutical composition comprising octreotide microparticles.
EC2005005800A ECSP055800A (en) 2002-11-19 2005-05-18 PHARMACEUTICAL COMPOSITION THAT INCLUDES OCTREOTIDE MICRO-PARTICLES
CO05050166A CO5690533A2 (en) 2002-11-19 2005-05-24 PHARMACEUTICAL COMPOSITION THAT INCLUDES OCTREOTIDE MICRO-PARTICLES
NO20052952A NO20052952L (en) 2002-11-19 2005-06-16 Pharmaceutical composition comprising microparticles
HK12101942.3A HK1161123A1 (en) 2002-11-19 2006-02-16 Pharmaceutical composition comprising octreotide microparticles
US11/650,701 US20070122485A1 (en) 2002-11-19 2007-01-08 Organic compounds
AU2008200018A AU2008200018B2 (en) 2002-11-19 2008-01-03 Pharmaceutical composition comprising octreotide microparticles
RU2010144614/15A RU2010144614A (en) 2002-11-19 2010-11-01 PHARMACEUTICAL COMPOSITION CONTAINING OCTREOTIDE MICROPARTICLES
AU2011200966A AU2011200966B2 (en) 2002-11-19 2011-03-04 Pharmaceutical composition comprising octreotide microparticles
JP2011165812A JP5784402B2 (en) 2002-11-19 2011-07-28 Pharmaceutical composition comprising octreotide microparticles
US14/330,485 US20140323415A1 (en) 2002-11-19 2014-07-14 Organic compounds
US15/627,619 US20170281548A1 (en) 2002-11-19 2017-06-20 Organic Compounds
US16/576,217 US20200009056A1 (en) 2002-11-19 2019-09-19 Organic compounds
US17/748,432 US20220273574A1 (en) 2002-11-19 2022-05-19 Organic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0226993A GB0226993D0 (en) 2002-11-19 2002-11-19 Organic compounds

Publications (1)

Publication Number Publication Date
GB0226993D0 true GB0226993D0 (en) 2002-12-24

Family

ID=9948131

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0226993A Ceased GB0226993D0 (en) 2002-11-19 2002-11-19 Organic compounds

Country Status (3)

Country Link
CN (1) CN100400098C (en)
GB (1) GB0226993D0 (en)
ZA (1) ZA200502748B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101439182B (en) * 2008-12-18 2012-02-01 北京大学 Somatostatin receptor mediated tumor-targeted medicament composition
CN109106688B (en) * 2018-08-22 2021-08-17 丽珠医药集团股份有限公司 Preparation method of octreotide acetate microspheres
CN116139256A (en) * 2023-03-14 2023-05-23 复旦大学附属肿瘤医院 Somatostatin/somatostatin analogue slow-release film and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
MY108621A (en) * 1990-08-01 1996-10-31 Novartis Ag Polylactide preparation and purification

Also Published As

Publication number Publication date
CN1711073A (en) 2005-12-21
ZA200502748B (en) 2005-10-13
CN100400098C (en) 2008-07-09

Similar Documents

Publication Publication Date Title
GB0203276D0 (en) Organic compounds
GB0209265D0 (en) Organic compounds
GB0205281D0 (en) Organic compounds
GB0209481D0 (en) Organic compounds
GB0226993D0 (en) Organic compounds
GB0203061D0 (en) Organic compounds
GB0202874D0 (en) Organic compounds
GB0204756D0 (en) Organic compounds
GB0211261D0 (en) Organic compounds
GB0209257D0 (en) Organic compounds
GB0210535D0 (en) Organic compounds
GB0229054D0 (en) Organic compounds
GB0209887D0 (en) Organic compounds
GB0205537D0 (en) Organic compounds
GB0206217D0 (en) Organic compounds
GB0205280D0 (en) Organic compounds
GB0205023D0 (en) Organic compounds
GB0207728D0 (en) Organic compounds
GB0207729D0 (en) Organic compounds
GB0207499D0 (en) Organic compounds
GB0207726D0 (en) Organic compounds
GB0200940D0 (en) Organic compounds
GB0204754D0 (en) Organic compounds
GB0211262D0 (en) Organic compounds
GB0206218D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)